The FDA grants full approval for AbbVie's Elahere, a drug for treating ovarian cancer, following its initial accelerated approval in November 2022, based on data from the MIRASOL Phase 3 study, after AbbVie's acquisition of ImmunoGen for approximately $10 billion.

Capital One assures regulators that its acquisition of Discover will not stifle credit card competition, as the combined entity will only represent 13% of purchasing volume, emphasizing the deal's potential to enhance financial stability and create a competitive alternative to Visa and Mastercard.

Capri Holdings (NYSE:CPRI) saw a partial recovery in stock value amid speculation as the Federal Trade Commission removed a scheduled closed-door meeting from its website, raising concerns about potential FTC actions regarding Capri's planned acquisition by Tapestry (NYSE:TPR).

Franworth sells its holdings in The Lash Lounge to Riverside Capital, marking the growth journey from a 6-unit business in Dallas, TX, to over 130 open and another 140 units sold, as Franworth re-capitalizes and transforms into a leader-led organization, with a mission to create brighter futures for founders, franchisor teams, and entrepreneurs.